TTR and obesity due to melanocortin 4 receptor deficiency: One of this study’s primary strengths is the large data set, including many patients with TTR-aHO, providing a comprehensive database for the validation of TTR-aHO through incident obesity, central AVP-D diagnosis, and desmopressin prescription.